Incretin|based therapy of metabolic disease

Incretin-based therapy of metabolic disease - PubMed

Recent studies show that incretin hormone analogues effectively control blood glucose while producing major weight losses and reducing the ...

Incretin-based therapy of metabolic disease | Ugeskriftet.dk

Evidence shows that the secretion of incretin hormones may be impaired in some patients (particularly secretion of GLP-1 in obese individuals), ...

Incretins in Metabolic Disease: Pathophysiology and Therapy

In this special issue we summarise the state-of-the-art knowledge about incretins, from basic biology and treatment modalities to socioeconomic aspects of ...

Incretin Hormones in Obesity and Related Cardiometabolic Disorders

Incretin mimetics present glucose-lowering properties, together with a reduction of appetite and food intake, resulting in weight loss.

Incretin-based therapies for the treatment of obesity-related diseases

Incretin-based therapies have been associated with a body weight (BW) reduction of ≥5% in at least half of patients in most randomized ...

Incretin‐based therapies for the management of cardiometabolic ...

Among newer classes of drugs for type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are incretin-based ...

Incretin-based therapy: a new horizon in diabetes management

This review focuses on the role of incretin-based therapies, particularly Glucagon-like peptide-1 (GLP-1) agonists and dipeptidyl peptidase-4 (DPP-4) ...

The Incretin Impact: a new era in metabolic disease and obesity ...

Incretin-based therapies are also being investigated in other indications and across several organs, and as such, have completely changed the treatment ...

The evolving story of incretins (GIP and GLP‐1) in metabolic and ...

The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have their main physiological role in augmenting ...

Incretins in Metabolic Disease: Pathophysiology and Therapy

There is currently significant attention surrounding glucose-lowering drugs based on incretins, a group of hormones released from the intestine that play a ...

Incretin - an overview | ScienceDirect Topics

Incretins are gut-derived hormones that stimulate pancreatic insulin secretion in a glucose-dependent manner. Incretins-based therapies interfere with disease ...

Incretin-based therapy of metabolic disease. - Abstract - Europe PMC

Recent studies show that incretin hormone analogues effectively control blood glucose while producing major weight losses and reducing the risk of all-cause ...

Incretin Hormones in Obesity and Related Cardiometabolic Disorders

Dysregulation of incretin secretion and actions has been observed in obesity and related metabolic disorders; therefore, incretin-based therapies have been ...

Paradigm Shift in the Management of Metabolic Diseases—Next ...

Recently impressive weight loss has been reported for novel incretin therapies based on dual-and triple-hormone receptor coagonists.

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Retaining lean mass during incretin therapy could blunt body weight (and fat) regain on cessation of weight loss pharmacotherapy. We propose ...

Incretin-based therapy of metabolic disease - ResearchGate

Download Citation | Incretin-based therapy of metabolic disease | Recent studies show that incretin hormone analogues effectively control blood glucose ...

Incretins and incretin-based therapies for obesity, diabetes and ...

Incretins and incretin-based therapies for obesity, diabetes and other metabolic disorders ... BMC Endocrine Disorders called for submissions to ...

Variation in responses to incretin therapy: Modifiable and non ...

Incretin therapy is the second line of treatment for T2D, improving both blood glucose regulation and weight loss. Glucagon-like peptide-1 (GLP- ...

Incretin-based Therapies in the Treatment of Metabolic Syndrome

Incretin-based Therapies in the Treatment of Metabolic Syndrome: Expanding Roles Beyond Weight Management

The role of incretin-based therapies in prediabetes: A review

In recent small studies, incretin based therapy (DPP IV inhibitors and GLP-1 agonists) have also been extended to patients with prediabetes since it was shown ...